101 related articles for article (PubMed ID: 1318513)
1. Platelet alpha-2 adrenergic receptor binding and plasma free 3-methoxy-4-hydroxyphenylethylene glycol in depressed patients before and after treatment with mianserin.
Kaneko M; Kanno T; Honda K; Mashiko H; Oosuga N; Watanabe A; Kumashiro H
Neuropsychobiology; 1992; 25(1):14-9. PubMed ID: 1318513
[TBL] [Abstract][Full Text] [Related]
2. Platelet membrane alpha 2-adrenergic receptors in depression.
Karege F; Bovier P; Widmer J; Gaillard JM; Tissot R
Psychiatry Res; 1992 Sep; 43(3):243-52. PubMed ID: 1359596
[TBL] [Abstract][Full Text] [Related]
3. The effect of mianserin on alpha-2 adrenergic receptor function in depressed patients.
Charney DS; Heninger GR; Sternberg DE
Br J Psychiatry; 1984 Apr; 144():407-16. PubMed ID: 6326924
[TBL] [Abstract][Full Text] [Related]
4. Platelet alpha 2-adrenergic receptors in depressed patients and healthy volunteers: the effects of desipramine.
Werstiuk ES; Auffarth SE; Coote M; Gupta RN; Steiner M
Pharmacopsychiatry; 1992 Jul; 25(4):199-206. PubMed ID: 1326772
[TBL] [Abstract][Full Text] [Related]
5. Platelet alpha 2-adrenergic receptor sensitivity in major depressive disorder.
Stahl SM; Lemoine PM; Ciaranello RD; Berger PA
Psychiatry Res; 1983 Nov; 10(3):157-64. PubMed ID: 6320244
[TBL] [Abstract][Full Text] [Related]
6. Platelet high affinity adrenoceptor binding sites labelled with the agonist [3H]UK-14,304, in depressed patients and matched controls.
Theodorou AE; Hale AS; Davies SL; Katona CL; Yamaguchi Y; Horton RW; Kelly JS; Paykel ES
Eur J Pharmacol; 1986 Jul; 126(3):329-32. PubMed ID: 3019719
[TBL] [Abstract][Full Text] [Related]
7. Platelet alpha 2-adrenoceptors, defined with agonist and antagonist ligands, in depressed patients, prior to and following treatment.
Theodorou AE; Lawrence KM; Healy D; Whitehouse AM; White W; Wilton-Cox H; Kerry SM; Horton RW; Paykel ES
J Affect Disord; 1991 Nov; 23(3):99-106. PubMed ID: 1685500
[TBL] [Abstract][Full Text] [Related]
8. Enhanced binding of [3H] (-) adrenaline to platelets of depressed patients with melancholia: effect of long-term clomipramine treatment.
Garcia-Sevilla JA; Udina C; Fuster MJ; Alvarez E; Casas M
Acta Psychiatr Scand; 1987 Feb; 75(2):150-7. PubMed ID: 3031932
[TBL] [Abstract][Full Text] [Related]
9. Effects of electroconvulsive therapy on peripheral adrenoceptors, plasma, noradrenaline, MHPG and cortisol in depressed patients.
Werstiuk ES; Coote M; Griffith L; Shannon H; Steiner M
Br J Psychiatry; 1996 Dec; 169(6):758-65. PubMed ID: 8968635
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment.
Charney DS; Heninger GR; Sternberg DE; Redmond DE; Leckman JF; Maas JW; Roth RH
Arch Gen Psychiatry; 1981 Dec; 38(12):1334-40. PubMed ID: 6274268
[TBL] [Abstract][Full Text] [Related]
11. Increased 3H-clonidine binding in the platelets of patients with depressive and schizophrenic disorders.
Pandey GN; Janicak PG; Javaid JI; Davis JM
Psychiatry Res; 1989 Apr; 28(1):73-88. PubMed ID: 2544917
[TBL] [Abstract][Full Text] [Related]
12. Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients.
Piletz JE; Halaris A; Saran A; Marler MR
Arch Gen Psychiatry; 1991 Sep; 48(9):813-20. PubMed ID: 1681792
[TBL] [Abstract][Full Text] [Related]
13. alpha 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine.
Heninger GR; Charney DS; Price LH
Arch Gen Psychiatry; 1988 Aug; 45(8):718-26. PubMed ID: 2840050
[TBL] [Abstract][Full Text] [Related]
14. Does plasma free-3-methoxy-4-hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium.
Nakamura J; Uchimura N; Yamada S; Nakazawa Y
Int Clin Psychopharmacol; 1997 May; 12(3):147-52. PubMed ID: 9248871
[TBL] [Abstract][Full Text] [Related]
15. Alpha 2-adrenergic receptor function in depression. The cortisol response to yohimbine.
Price LH; Charney DS; Rubin AL; Heninger GR
Arch Gen Psychiatry; 1986 Sep; 43(9):849-58. PubMed ID: 3019271
[TBL] [Abstract][Full Text] [Related]
16. Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects.
Sevy S; Papadimitriou GN; Surmont DW; Goldman S; Mendlewicz J
Biol Psychiatry; 1989 Jan; 25(2):141-52. PubMed ID: 2539200
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects.
Siever LJ; Uhde TW; Jimerson DC; Lake CR; Silberman ER; Post RM; Murphy DL
Am J Psychiatry; 1984 Jun; 141(6):733-41. PubMed ID: 6329004
[TBL] [Abstract][Full Text] [Related]
18. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine.
Siever LJ; Uhde TW
Biol Psychiatry; 1984 Feb; 19(2):131-56. PubMed ID: 6324896
[TBL] [Abstract][Full Text] [Related]
19. Platelet alpha 2-adrenoreceptor binding in elderly depressed patients.
Doyle MC; George AJ; Ravindran AV; Philpott R
Am J Psychiatry; 1985 Dec; 142(12):1489-90. PubMed ID: 3000201
[TBL] [Abstract][Full Text] [Related]
20. Elevated 3H-para-aminoclonidine binding to platelet purified plasma membranes from depressed patients.
Piletz JE; Halaris A; Saran A; Marler M
Neuropsychopharmacology; 1990 Jun; 3(3):201-10. PubMed ID: 1973039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
